Apremilast (Otezla) for Psoriatic Arthritis

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2014年 / 56卷 / 1443期
关键词：
CONTROLLED-TRIAL; EFFICACY; MODERATE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：41 / 42
页数：2
相关论文
共 50 条
  • [1] Apremilast (Otezla®), an immunosuppressant
    Buxeraud, Jacques
    Faure, Sebastien
    ACTUALITES PHARMACEUTIQUES, 2023, 62 (623): : 11 - 13
  • [2] Apremilast in psoriatic arthritis
    Schett, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (05) : S98 - S100
  • [3] Apremilast in Psoriatic Arthritis
    不详
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (05): : 393 - 393
  • [4] Apremilast for psoriatic arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2024, 6 (10): : e666 - e666
  • [5] Apremilast for the treatment of psoriatic arthritis
    Varada, Sowmya
    Tintle, Suzanne J.
    Gottlieb, Alice B.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (03) : 239 - 250
  • [6] Apremilast for the treatment of psoriatic arthritis
    Souto, Alejandro
    Gomez-Reino, Juan J.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (12) : 1281 - 1290
  • [7] Apremilast Use in Oligoarticular Psoriatic Arthritis
    Torrente-Segarra, Vicenc
    Bonet, Maria
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (11) : 1293 - 1294
  • [8] Oral Apremilast Monotherapy and Psoriatic Arthritis
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (12) : 1492 - 1493
  • [9] Apremilast: A Review in Psoriasis and Psoriatic Arthritis
    Gillian M. Keating
    Drugs, 2017, 77 : 459 - 472
  • [10] Apremilast: A Review in Psoriasis and Psoriatic Arthritis
    Deeks, Emma D.
    DRUGS, 2015, 75 (12) : 1393 - 1403
12345